FDA Clears New Phosphate Binder VelphoroFDA Clears New Phosphate Binder Velphoro

Sucroferric oxyhydroxide (Velphoro) is an iron-based, calcium-free, chewable phosphate binder for treatment of hyperphosphatemia in patients with chronic kidney disease who are receiving dialysis. FDA Approvals
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Nephrology News Alert Source Type: news